Coupling Gd‑DTPA with a bispecific, recombinant protein anti‑EGFR‑iRGD complex improves tumor targeting in MRI

scientific article published on 29 March 2016

Coupling Gd‑DTPA with a bispecific, recombinant protein anti‑EGFR‑iRGD complex improves tumor targeting in MRI is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3892/OR.2016.4712
P932PMC publication ID4872280
P698PubMed publication ID27035336
P5875ResearchGate publication ID299503186

P2093author name stringBing Zhang
Baorui Liu
Bin Zhu
Xiaoyan Xin
Huizi Sha
Jingtao Shen
P2860cites workA caged lanthanide complex as a paramagnetic shift agent for protein NMR.Q30342068
Large relaxivity enhancement of paramagnetic lipid nanoparticles by restricting the local motions of the Gd(III) chelatesQ33580772
Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugsQ33897492
Targeted probes for cardiovascular MRIQ33901726
Molecular imaging in cancerQ34530970
Binding of a C-end rule peptide to the neuropilin-1 receptor: a molecular modeling approachQ34634376
Facile labelling of an anti-epidermal growth factor receptor Nanobody with 68Ga via a novel bifunctional desferal chelate for immuno-PET.Q34648047
Tumor-penetrating iRGD peptide inhibits metastasisQ34978216
Tissue-penetrating delivery of compounds and nanoparticles into tumorsQ35016106
High-performance nanostructured MR contrast probesQ35031050
Tumor targeting with RGD peptide ligands-design of new molecular conjugates for imaging and therapy of cancersQ36952035
Tumor-penetrating peptide fused EGFR single-domain antibody enhances cancer drug penetration into 3D multicellular spheroids and facilitates effective gastric cancer therapyQ37224751
Targeting tumors with nanobodies for cancer imaging and therapy.Q38137610
Nanobodies targeting the hepatocyte growth factor: potential new drugs for molecular cancer therapyQ39399346
SPECT imaging with 99mTc-labeled EGFR-specific nanobody for in vivo monitoring of EGFR expressionQ40009259
A novel polyacrylamide magnetic nanoparticle contrast agent for molecular imaging using MRI.Q40538607
Evasion of the Accelerated Blood Clearance Phenomenon by Coating of Nanoparticles with Various Hydrophilic PolymersQ42925153
Versatile and selective synthesis of "click chemistry" compatible heterobifunctional poly(ethylene glycol)s possessing azide and alkyne functionalitiesQ43193245
Noninvasive monitoring of the fate of 111In-labeled block copolymer micelles by high resolution and high sensitivity microSPECT/CT imagingQ43283369
Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomographyQ43561095
Micro-PET imaging of alphavbeta3-integrin expression with 18F-labeled dimeric RGD peptideQ45008593
MicroPET imaging of breast cancer alphav-integrin expression with 64Cu-labeled dimeric RGD peptidesQ45068701
P433issue6
P304page(s)3227-3235
P577publication date2016-03-29
P1433published inOncology ReportsQ7092098
P1476titleCoupling Gd‑DTPA with a bispecific, recombinant protein anti‑EGFR‑iRGD complex improves tumor targeting in MRI
P478volume35

Reverse relations

cites work (P2860)
Q58781545Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment
Q48550017Dual-Targeted Molecular Imaging of Cancer
Q91793873Imaging strategies in the management of gastric cancer: current role and future potential of MRI
Q92336348Using Omniscan-Loaded Nanoparticles as a Tumor-Targeted MRI Contrast Agent in Oral Squamous Cell Carcinoma by Gelatinase-Stimuli Strategy
Q92187150iRGD: A Promising Peptide for Cancer Imaging and a Potential Therapeutic Agent for Various Cancers